Biotech - News Headlines

The Latest: Congressman to remain on ballot despite charges
August 9th, 2018  2:17 AM

Republican Rep. Chris Collins says he will remain on the ballot running for re-election in New York as he fights charges that he used inside information about a biotechnology company to make illicit stock trades

Legal proceedings news icon
The Latest: Congressman pleads not guilty to insider trading
August 8th, 2018  2:58 PM

U.S. Rep. Chris Collins has pleaded not guilty to insider trading charges

Legal proceedings news icon
Groupon, JPMorgan Chase rise, Twitter, CTI BioPharma fall
July 9th, 2018  4:36 PM

Groupon, JPMorgan Chase rise, Twitter, CTI BioPharma fall

News Icon
Rhode Island considers tax credits for biotech company
June 28th, 2018  12:27 PM

Rhode Island is considering using tax incentives to attract a Massachusetts pharmaceutical company

Government and politics news icon
X-rays and soy on front lines of US-China trade spat
June 15th, 2018  1:55 PM

X-ray machines, soybeans on front lines of US-China trade spat

Economy news icon
$1.5B settlement in suit over Syngenta modified corn seed
March 13th, 2018  9:44 AM

A $1.5 billion settlement has been reached in a class-action lawsuit against Swiss agribusiness giant Syngenta over its introduction of a genetically engineered corn seed

Technology news icon
Settlement reached in suit over Syngenta modified corn seed
March 12th, 2018  8:50 PM

A Swiss agribusiness giant has agreed to a $1.5 billion settlement in a lawsuit over its introduction of a genetically engineered corn seed

Energy industry news icon
Can gene therapy be harnessed to fight the AIDS virus?
February 13th, 2018  1:27 AM

Scientists are trying gene therapy to fight HIV, the virus that causes AIDS

Can gene therapy be harnessed to fight the AIDS virus?
LA Times buyer is a basketball-loving biotech billionaire
February 7th, 2018  2:43 PM

The man buying the Los Angeles Times is a 65-year-old physician-entrepreneur described by Forbes Magazine as "America's richest doctor."

Patrick Soon-Shiong
2nd man has gene editing; therapy has no safety flags so far
February 6th, 2018  7:33 PM

Doctors have treated a second patient in a historic gene editing study in California

2nd man has gene editing; therapy has no safety flags so far
Johnson & Johnson loses $10.7B after sweeping US tax changes
January 23rd, 2018  4:24 PM

Johnson & Johnson reports 4th-quarter loss of $10.71 billion due to charge for tax law changes, higher spending

Johnson & Johnson loses $10.7B after sweeping US tax changes
Martin Shkreli's ex-lawyer found guilty of financial fraud
December 28th, 2017  12:33 AM

A lawyer accused of helping pharmaceutical entrepreneur Martin Shkreli cover up financial fraud has been convicted in New York

defense attorney Baruch White; Martin Shkreli; defense attorney Jonathan Sack co-defendant Evan Greebel
Gene therapy for rare form of blindness wins US approval
December 19th, 2017  1:24 PM

U.S. health officials approve gene therapy that can restore the sight of patients with a rare form of inherited blindness

Gene therapy for rare form of blindness wins US approval
AP Exclusive: US scientists try 1st gene editing in the body
November 15th, 2017  10:19 AM

American scientists for the first time have tried editing a gene inside the body in hope of curing a disease.

AP Exclusive: US scientists try 1st gene editing in the body
Swiss biotech group Roche sees 5 pct rise in 9-month sales
October 19th, 2017  4:12 AM

Swiss biotech company Roche says sales grew 5 percent in the first nine months of the year, crediting new product launches and citing double-digit growth in the pharmaceuticals division in the U.S. market

Corporate news news icon
Seeing hope: FDA panel considers gene therapy for blindness
October 9th, 2017  10:47 PM

Advisers to the U.S. Food and Drug Administration will meet Thursday to consider whether to recommend approval of a gene therapy aimed at restoring vision for some people with hereditary blindness

Seeing hope: FDA panel considers gene therapy for blindness
Syngenta settles US farmer lawsuits in China corn trade case
September 26th, 2017  6:40 PM

Swiss agribusiness giant Syngenta has agreed to settle tens of thousands of US lawsuits by farmers over the company's introduction of a genetically engineered corn seed variety before China approved it for imports

Syngenta settles US farmer lawsuits in China corn trade case
European court sides with Italian farmer pushing GM crops
September 13th, 2017  10:36 AM

The European Union court has ruled in favor of an Italian activist farmer who has defied his nation's laws by planting genetically modified corn

Government regulations news icon
Alexion Pharmaceuticals is moving its headquarters to Boston
September 12th, 2017  4:25 PM

Alexion Pharmaceuticals Inc. has announced that it is relocating its headquarters from New Haven, Connecticut, to Boston

Corporate news news icon
Alexion Pharmaceuticals is moving its headquarters to Boston
September 12th, 2017  12:22 PM

Alexion Pharmaceuticals Inc. has announced that it is relocating its headquarters from New Haven, Connecticut, to Boston

Corporate news news icon

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.